Sort   by:  
 Page size 
UnknownRandomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
Not available
S-EPMC3157978 | biostudies-literature
UnknownPooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.
Not available
S-EPMC6075828 | biostudies-literature
UnknownRandomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.
Not available
S-EPMC3397694 | biostudies-literature
TranscriptomicsTranscription profiling of human early stage non-small cell lung carcinoma to refine prognosis for adjuvant therapy
Abstract from paper - Potti A, et al Experiment Overall Design: Retrospective analysis of approximately 200 samples obtained from Duke, ACOSOG and CALGB to develop a Lung metagene predictor that would then be used to assess risk of recurrence and thus identify high risk patients with stage Ia non-sm...
ORGANISM(S): Homo sapiens 
2008-06-12 | E-GEOD-3593 | biostudies-arrayexpress
Sort   by:  
 Page size